BACKGROUND
The incidence of Type 1 diabetes is rising globally [1] . As a leading cause of heart attacks, stroke and amputation the burden on people living with diabetes and health services is considerable. Well targeted research has a key role to play in the development of evidence based treatments for the management and self-management of Type 1 diabetes. People living with diabetes are well placed to contribute to the development of this research in many ways, including suggesting areas for research they consider most important.
An important rationale for patient and public involvement (PPI) is that research carried out 'with' members of the public rather than 'to', 'about' or 'for' them should lead to research that is more relevant to people's needs [2] . Public involvement in the design and conduct of health research has developed significantly in recent years, and is now seen as a core component of good research practice. Major UK research funders such as the National Institute for Health Research and the Medical Research Council have patient and public representation on funding panels and require funding applications to demonstrate evidence of PPI [3] .
For PPI to be meaningful patients and the public need to be able to exert influence throughout the research process, including the development of research agendas. Exploring issues of utility and acceptability to patients before the agenda is set may increase uptake of research [4] , generate research that is of interest to patients, allow outcomes meaningful to patients to be researched and reduce waste [5 6] . Applying the INVOLVE definition of PPI above there are few studies that report involving patients and carers in agenda setting for diabetes research. An exception is the James Lind Alliance's top ten research priorities created in partnership with clinicians, patients and carers [7] .
Many diabetes agenda setting studies simply omit the patient perspective [8 9] .
Studies that do report patient's diabetes research agendas often do not meet basic PPI principles because the methods used to draw out these agendas effectively reduce patients to the level of research subjects. This is true for surveys, questionnaires, focus groups especially [10 11 ]. These methods can effectively form part of a PPI agenda setting exercise, but on their own offer no opportunity for active involvement or representation and may create a mismatch between patients'
and researchers' agendas. Further distortion can occur when prioritising research agendas as patient and carer questions may be at greater risk of rejection from the agenda setting process [12] .
It is important then to compare research agendas to ensure that patients' concerns are reflected in ongoing research. Studies comparing the health research agendas of the public with those of researchers are very rare [13 14] . A literature search carried out in relation to the study we report on here only located two such comparisons of diabetes research agendas by one author [11 15] . The first study compared patient and researcher preferences and found a mismatch and the second compared the proportions of research topics and also found that the distribution of funded research did not reflect patient concerns. The aim of this study was to explore the divergence and convergence between the research agenda demonstrated in funded Type 1 diabetes projects and the research agenda of people with Type 1 diabetes and carers conveyed using facilitative methods. This provides a rare opportunity for an exploration of an agenda directly expressed by patients and carers in their own words.
SETTING
This study uses existing data from two UK organisations who regularly work with patients and carers to identify research priorities. The first organisation is the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula (PenCLAHRC) [16] . PenCLAHRC involves patients and carers in both the identification and prioritisation of research questions that address patient and clinical concerns [17] . Workshop attendees were typically retired and white, reflecting the local South West demographic.
The largest proportion of patient questions was provided by the second organisation, the James Lind Alliance (JLA), which is a non-profit making initiative founded in 2004. It brings patients, carers and healthcare professionals together in Priority Setting Partnerships to identify and prioritise the unanswered questions about treatments that they agree are most important [18] . Priority Setting Partnerships work to identify and prioritise the uncertainties, or unanswered questions, about treatments which patients, carers and clinicians want research to address. In the first stage of these partnerships patient, carer and clinician uncertainties are gathered through a survey where respondents can write their questions in free text, without prior framing by researchers [19] . During the same time period as the PenCLAHRC workshops, research ideas were submitted by people with diabetes to the JLA Type 1 diabetes Priority Setting Partnership, which was funded by The Insulin individual patient questions were available for analysis.
Data collection: Funded research studies
Searches were conducted on 18 websites and databases, identified in consultation with an information specialist, containing information about UK research funding related to diabetes (see Table 1 for details). 
Funder type categories:
Mixed: these sources contained multiple types of research funder including charity (diabetes and other), UK government funding and industry.
Diabetes Charity: these sources only funded research related to diabetes. Funds raised through charitable means.
Charity (other): These sources funded research into different conditions and types of biomedical research, including T1D.
Funds raised through charitable means.
UK Government: These sources funded research into different conditions and types of biomedical research, including T1D.
Funds provided by grants via government research organisations.
Industry: These sources funded research into different conditions and types of biomedical research, including Type 1Diabetes.
Funds provided by business and pharmaceutical companies.
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DATA ANALYSIS
Both datasets were individually thematically analysed in order to identify inductively emergent research themes [21] . For each dataset the initial stage of analysis involved familiarisation with the data by KB, resulting in the initial development of a list of recurrent codes. KC also independently undertook an initial analysis of a subset of both datasets. Specialist knowledge was provided by a consultant endocrinologist who assisted in identifying codes for the funded research data. NVivo, a qualitative software indexing program, was used to facilitate data organisation, coding and retrieval.
To develop the codes each question and research study was considered in terms of its key focus. For example, the question "Can homeopathic medicines provide beneficial use in diabetic care?" was coded to the category 'Alternative therapies'. KC and KB then met to consult on the codes generated and to discuss, refine and agree a set of codes for each dataset. KB completed the coding of both datasets, in frequent consultation with KC as well as a third researcher (AG). KC and KB met to reach a consensus on the key themes from both data sets. Finally both data sets were interpreted as a whole, identifying areas of divergence and convergence.
RESULTS
The results showed that there is notable convergence between the two research agendas; there are also some notable areas of divergence. We will explore areas of divergence in greater depth than the convergent themes in an attempt to understand what is missing from the agenda from a patient's point of view.
Areas of convergence
The two main convergent themes were 'control and complications' and 'causes and cures'. 'Control and complications' was the main theme for both the funded research agenda and the patient research agenda. This broad theme relates to all aspects of blood sugar control and complications associated with Type 1 diabetes. Monitoring blood sugar levels was a key area of uncertainty; both agendas were interested in finding better methods of monitoring blood glucose both in terms of providing greater accuracy and in providing more acceptable and less invasive methods. Uncertainties about managing control in particular circumstances, such as exercise, were identified in both datasets. There was also "This research will be important for understanding why people develop T1DM."
While there are clear differences between the ways in which the funded research questions and people with diabetes express the notion of control and complications, and causes and cures, the data suggested that funded studies are addressing priority areas for the end users of those studies.
Areas of divergence
The main divergent themes were: care delivery, injection issues, psychosocial impacts, and women's health.
Care delivery
The theme of 'care delivery' featured in both agendas, but there was little agreement on the topics to be researched. People with diabetes expressed two main aspects of care delivery in need of further research: access to equipment and variation in care. While the first was concerned with the day-to- So while 'Care delivery' was prioritised in both funded research and patient questions there was a clear difference in focus. From the perspective of people with diabetes lack of service provision is a major concern. From the perspective of researchers an important concern is services not being used.
This demonstrates how an apparently shared priority may host significant differences in emphasis between patient generated and funded research agendas.
Injection issues
This theme was clearly important to people with diabetes while notably absent in the funded research. It is not possible to ascertain from the data whether the question submitters were aware of the existing difficulties in these research fields and previous attempts to develop alternative methods and are calling for renewed development in these areas or whether they are posing a novel approach. Be that as it may, our data shows that patients want alternatives to be "quicker and pain free", "make life easier" and be a better method of delivery than the "very painful and inconvenient" injections. The extent of these questions and the recurring topic of pain provide insight into outcomes that are important to people with diabetes.
Psychosocial impacts
The theme of 'psychosocial impacts' of diabetes covered a range of concerns such as peer support, psychological wellbeing and its effects on diabetes management and the mental health effects of In this theme people with diabetes seemed to be aware of the divergence between their interests and current research. The questions pointed out that this was an area felt by patients to be underresearched and that other topics were given prominence. This was not apparent in other themes: This divergence around menstruation and menopause, affecting all women with Type 1 diabetes, suggests to us that researchers not only need to talk to patients about their interests and concerns.
They also need to ensure they are reaching diverse groups within those patient communities
LIMITATIONS
This study is based on a relatively large sample of patient and carer questions which have not been The theme of 'care delivery' was present in both research agendas. The funded research was concerned with adherence and screening whilst the public research agenda focused on the inequalities and variation in care. Our exploration of these research agendas suggests that involvement is needed to ensure that patient concerns are fully reflected within an agenda, avoiding superficial agreement which masks differences of perspective within a topic.
Where people with diabetes have expressed uncertainties that already have an existing and adequate evidence base, such as a reliable systematic review, this suggests that research findings are not to a wider range of audiences. In topics where the evidence base is known to the public yet the topic is repeatedly put forward as a priority then consideration needs to be given as to whether those services or treatments are adequately addressing patient needs.
Our findings suggest that funded diabetes research may be neglecting questions about the everyday reality of living with Type 1 diabetes, about quality of life including pain, and about the particular needs of women at different stages of the life cycle. They suggest how the diabetes research community could increase the relevance of its work for patients [22] . Given the increasing emphasis on self-management [23] , these results show how researchers can better support and engage the patient community.
It is encouraging for the Type1 diabetes community that our study found high levels of agreement.
However the recent paper by Crowe et al [14] demonstrates a continued divergence in health research agenda's generally. Our work suggests that there may be significant variation between specific conditions and within condition topics. The data generated by these exercises creates great potential for marrying up the two agendas and enhancing both communication of convergence and action to address divergence.
The findings of this research contribute to the limited evidence base around public involvement and research agenda setting. We demonstrate the need for considered, meaningful and direct involvement of patients in agenda setting that includes diverse groups within specific patient communities to ensure that the full range of issues experienced by people living with healthcare conditions can be addressed.
AUTHORSHIP
Kate Boddy has made substantial contributions to the conception and design of the study. She undertook the acquisition, analysis and interpretation of data for the study. She drafted the work and has given final approval of the version to be published. She agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Katherine Cowan has made substantial contributions to the conception and design of the study. She undertook the acquisition, analysis and interpretation of data for the study. She drafted the work and has given final approval of the version to be published. She agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Andy Gibson has made substantial contributions to the conception and design of the study and interpretation of data. He revised it critically and has given final approval of the version to be Nicky Britten has made substantial contributions to the conception and design of the study and interpretation of data. She revised it critically and has given final approval of the version to be published. She agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
CONFLICTS OF INTEREST
The authors declare that they have no competing interests. A total of 859 individual research questions were collected from patients and carers. Diabetes research funding activity was identified through extensive online searches which provided a total of 172 relevant research projects for analysis.
Results
The data were thematically analysed and areas of priority for research identified and compared between the patient and funded research agendas. The overall finding of this study is that there is substantial convergence between the two research agendas, alongside some important areas of divergence. The key areas of divergence were found in care delivery, injection issues, psychosocial impacts and women's health. We also demonstrate how an apparently convergent priority can host significant differences in emphasis between patient generated and funded research agendas.
Conclusions
We offer a comparison of a funded research agenda with one that has been derived directly from people with Type 1 diabetes without initial framing by researchers. This provided a rare opportunity to explore the viewpoints of the end users of research and compare them to realised research as determined by researchers and research organisations.
Strengths and limitations of this study
• Empirical comparison of the research agendas of people with type 1 diabetes and funded research in this field.
• This is a rare opportunity to explore the research agendas of people with type 1 diabetes, in their own words, through thematic analysis. 
BACKGROUND
The incidence of Type 1 diabetes is rising globally [1] . As a leading cause of heart disease, stroke and amputation the burden on people living with diabetes and health services is considerable [2] . Well targeted research has a key role to play in the development of evidence based treatments for the management and self-management of Type 1 diabetes. People living with diabetes are well placed to contribute to the development of this research in many ways, including suggesting areas for research they consider most important.
A key rationale for patient and public involvement (PPI) is that research carried out with members of the public should lead to research that is more relevant to people's needs [3] . Public involvement in the design and conduct of health research has developed significantly in recent years, and is now seen as a core component of good research practice. Major UK research funders such as the National Institute for Health Research and the Medical Research Council have patient and public representation on funding panels and require funding applications to demonstrate evidence of PPI [4] .
For PPI to be meaningful patients and the public need to be able to exert influence throughout the research process, including the development of research agendas. Exploring issues of utility and acceptability to patients before the agenda is set may increase uptake of research [5] , generate research that is of interest to patients, allow outcomes meaningful to patients to be researched and reduce waste [6 7] . INVOLVE, the National Institute for Health Research's advisory body for public involvement, define PPI as "research carried out 'with' members of the public rather than 'to', 'about' or 'for' them" [3] . Applying this definition of PPI, there are few studies that report involving patients and carers in agenda setting for Type 1 diabetes research. An exception is the James Lind Alliance's top ten research priorities created in partnership with clinicians, patients and carers [8] . Many diabetes agenda setting studies simply omit the patient perspective [9 10 ].
Studies that do report patients' diabetes research agendas often do not meet the INVOLVE definition of involvement above since the methods used to draw out these agendas effectively reduce patients to the level of research subjects; the research is 'about' them rather than conducted 'with' them. This is true for surveys, questionnaires and focus groups especially [11 12] . These methods can be employed, as just one stage, within a wider collaborative agenda setting process where involvement exists from beginning to end [13 14 ]. On their own, however, they offer no opportunity for active involvement because the participants are undertaking agenda setting tasks where there has been prior framing by the researchers. Ultimately this may contribute to a supposed patient agenda that aligns with that of researchers when in reality a mismatch between the two exists. Further distortion can occur when prioritising research agendas as patient and carer questions may be at greater risk of rejection from the agenda setting process [15] .
It is important then to compare research agendas to ensure that patients' concerns are reflected in ongoing research. Studies comparing the health research agendas of the public with those of [16] , compiling data from ongoing clinical trials [17] and using published abstracts from a relevant conference [18] .
The aim of this study was to explore the divergence and convergence between the agenda demonstrated in Type 1 diabetes research and the research agenda of people with Type 1 diabetes and carers elicited using participatory approaches aligned with the principles of public involvement [19 20 ]. This provides a rare opportunity for an exploration of an agenda directly expressed by patients and carers in their own words.
SETTING
This study uses existing data from two UK organisations who regularly work with patients and carers to identify research priorities. The first organisation is the National Institute for Health Research Network, the JLA and NHS Evidence -diabetes. The JLA Type 1 diabetes partnership method for priority setting is described in detail elsewhere [8] . A total of 877 individual uncertainties were collected from patients and carers. After removing items that were not related to Type 1 diabetes (e.g. about Type 2 diabetes or an unrelated topic) 859 individual patient questions were available for analysis.
METHODS
Data collection: Funded research studies
To establish a comparative, researcher-derived, data set we searched for information about research that had been funded within the same time period as the 'patient' agenda setting exercises (Jan 2010
to Dec 2011). We defined 'funded research' as UK-based research that was ongoing e.g. a clinical trial in the recruitment phase or research that had been approved for funding by a provider but was not yet underway. By limiting our inclusion criteria to recently funded or newly underway studies we hoped to derive an agenda that was as chronologically close as possible to the patient agenda whilst still using publically available existing data. Searches were conducted on 18 websites and databases, identified by an information specialist, to obtain data about diabetes research funded between Jan 2010 and Dec 2011 in the UK (see Table 1 for details).
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Of the 18 sources initially searched, 12 contained information related to Type 1 diabetes research (table 1) . To reduce the likelihood of a bias in the research projects analysed, in terms of type of research, extensive attempts were made to cover a full range of research funders including social research funders, rather than simply biomedical research funders (which were easier to locate due to trials registers etc). None of the social research funders searched resulted in Type 1 diabetes research projects within the time period of interest although they had previous links with diabetes research which was why they were included in the search process. The breakdown of the number of research projects that were analysed by funder type is as shown in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Funder type categories:
Charity (other):
These sources funded research into different conditions and types of biomedical research, including T1D.
Ethics Statement
We consider our study to be exempt from requiring ethical approval. The original public involvement agenda setting activities conducted by the JLA and PenCLAHRC, described above, were exempt from requiring ethical approval under guidance published by the NHS National Patient Safety Agency National Research Ethics Service (NRES) and INVOLVE [24] . The data from those activities are publically available [25] . This is a secondary analysis of that existing data.
DATA ANALYSIS
Both datasets were individually thematically analysed in order to identify inductively emergent research themes [26] . For each dataset the initial stage of analysis involved familiarisation with the data by KB, resulting in the initial development of a list of recurrent codes. KC also independently undertook an initial analysis of a subset (10%) of both datasets. Specialist knowledge was provided by a consultant endocrinologist who assisted in identifying codes for the funded research data. NVivo, a qualitative software indexing program, was used to facilitate data organisation, coding and retrieval.
RESULTS
The results showed that there is convergence between the two research agendas; there are also some notable areas of divergence. We will explore areas of divergence in greater depth than the convergent themes in an attempt to understand what is missing from the agenda from a patient's point of view.
Areas of convergence
'Control and complications' was an important theme for both the funded research agenda and the patient research agenda. This broad theme relates to all aspects of blood sugar control and complications associated with Type 1 diabetes. Monitoring blood sugar levels was a key area of uncertainty; both agendas were interested in finding better methods of monitoring blood glucose both in terms of providing greater accuracy and in providing more acceptable and less invasive methods.
Uncertainties about managing control in particular circumstances, such as exercise, were identified in people with diabetes express the notion of control and complications, and causes and cures, the data suggested that funded studies are addressing priority areas for the end users of those studies.
Areas of divergence
Notable divergent themes were: care delivery, injection issues, psychosocial impacts, and women's health.
Care delivery
The theme of 'care delivery' featured in both agendas, but there was little agreement on the topics to be researched. For people with diabetes they were two aspects of care delivery in need of further research: access to equipment and variation in care. While the first was concerned with the day-today mechanisms of managing Type 1, both topics were informed by the unequal treatment that people with diabetes can experience, depending on location and local policies. People felt that better provision of essential items, such as blood test strips, would be cost saving in the long term by So while 'Care delivery' was prioritised in both funded research and patient questions there was a clear difference in focus. From the perspective of people with diabetes lack of service provision is a major concern. From the perspective of researchers an important concern is services not being used.
Injection issues
This theme was clearly important to people with diabetes while notably absent in the funded research. It is not possible to ascertain from the data whether the question submitters were aware of the existing evidence base and the difficulties in these research fields (e.g. limited absorption and enzyme degradation) [27] , and are calling for renewed development in these areas or whether they are asking for a novel approach. Be that as it may, our data shows that patients want alternatives to be "quicker and pain free", "make life easier" and be a better method of delivery than the "very painful and inconvenient" injections. The extent of these questions and the recurring topic of pain provide insight into outcomes that are important to people with diabetes.
Psychosocial impacts
The theme of 'psychosocial impacts' of diabetes covered a range of concerns such as peer support, psychological wellbeing and its effects on diabetes management and the mental health effects of living with diabetes. This topic was of importance for people with diabetes yet was absent from the funded research agenda. People with diabetes were interested in the way in which psychosocial aspects effect their management and control of blood glucose: 
CONCLUSION
Using two robust direct methods of public engagement, this study found an encouraging level of agreement between the research agenda of people with Type 1 diabetes and that of recent funded research. Despite this convergence important concerns for people with Type 1 diabetes were conspicuously absent from the funded research. Absent topics included questions about the effects of menopause and menstruation on diabetes management and questions about how the pain and impact of injecting could be removed. Also absent were questions about the psychosocial impacts of living with diabetes. Questions within this topic were the only ones that pointed to an awareness of a divergence from the funded research agenda.
The theme of 'care delivery' was present in both research agendas. The funded research was concerned with adherence and screening whilst the public research agenda focused on the inequalities and variation in care. Our exploration of these research agendas suggests that involvement is needed to ensure that patient concerns are fully reflected within an agenda, avoiding superficial agreement which masks differences of perspective within a topic.
Where people with diabetes have expressed uncertainties that already have an existing evidence base this suggests that research findings are not reaching the patient community requiring better communication of research and better dissemination to a wider range of audiences. However, if a topic is repeatedly put forward as a priority despite an existing evidence base (e.g. oral insulin), whether this is known to the public or not is almost irrelevant, as consideration needs to be given as to whether those services or treatments are adequately addressing patient needs. It is encouraging for the Type1 diabetes community that our study found considerable agreement between the two agendas. However the recent paper by Crowe et al [17] demonstrates a continued divergence in health research agenda's generally. Our work suggests that there may be significant variation between specific conditions and within condition topics. The data generated by these exercises creates great potential for marrying up the two agendas and enhancing both communication of convergence and action to address divergence.
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